Introduction: Corona virus is a group of viruses that cause diseases in mammals and birds.
In humans, these families of viruses can cause respiratory infections from a mild form to fatal …

Background: Severe pneumonia and acute respiratory distress syndrome (ARDS) due to
COVID-19 is a challenge for nowadays medical practice. Although there is no clarity in the …

Abstract Coronavirus Disease 2019 (COVID-19) continues to spread rapidly. Monoclonal
antibodies as well as anti-tumor necrosis factor are considered promising treatments for …

Abstract Coronavirus disease 2019 (Covid‐19) is the illness caused by severe acute
respiratory syndrome coronavirus 2, first identified in Wuhan, China at the end of 2019. On …

Background The release of pro-inflammatory cytokines, resulting in cytokine storm
syndrome, contributes to the morbidity and mortality associated with COVID-19 disease. This …

Among patients suffering from coronavirus disease 2019 (COVID-19) syndrome, one of the
worst possible scenarios is represented by the critical lung damage caused by the severe …

Coronavirus disease 2019 (COVID-19) rapidly emerged as a global pandemic, placing
imminent stress and burden on healthcare resources and workers worldwide. Many patients …

To date, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) has infected
millions of individuals worldwide. This virus causes coronavirus disease 2019 (COVID-19) …

Presently, we need more therapeutic molecules for this COVID-19 outbreak. The severity
and mortality of the disease is associated with a high level of release of cytokine in the …

Since December 2019, a novel coronavirus pneumonia (COVID-19) has broken out in
Wuhan, China and spread rapidly. Recent studies have found that⁓ 15.7% of patients …